GlycoPharma Holding ApS — Credit Rating and Financial Key Figures

CVR number: 39691558
Rørhatten 4, Tornbjerg 5220 Odense SØ

Income statement (kDKK)

2019
2020
2021
2022
2023
Fiscal period length1212121212
Net sales
External services-7.47-12.12
Gross profit-7.47-12.12-8.10-13.64-15.53
EBIT-7.47-12.12-8.10-13.64-15.53
Other financial income6.752.500.17
Other financial expenses-0.02-0.03-0.01-0.00
Pre-tax profit-0.74-9.64-8.11-13.64-15.36
Income taxes0.121.520.82
Net earnings-0.62-8.12-7.29-13.64-15.36

Assets (kDKK)

2019
2020
2021
2022
2023
Intangible assets total
Tangible assets total
Holdings in group member companies229.16557.17
Participating interests557.17686.57801.77
Investments total229.16557.17557.17686.57801.77
Non-curr. owed by group member comp.162.36
Long term receivables total162.36
Inventories total
Current amounts owed by group member comp.8.630.841.743.30
Current deferred tax assets0.12485.04873.25
Short term receivables total8.75485.88874.993.30
Cash and bank deposits4.711.200.790.543.82
Cash and cash equivalents4.711.200.790.543.82
Balance sheet total (assets)404.971 044.251 432.95690.41805.59

Equity and liabilities (kDKK)

2019
2020
2021
2022
2023
Share capital102.41133.13133.13134.96137.51
Retained earnings212.26288.92280.80462.97574.43
Profit of the financial year-0.62-8.12-7.29-13.64-15.36
Shareholders equity total314.06413.94406.65584.29696.58
Non-current deferred tax liabilities483.40388.28
Non-current liabilities total483.40388.28
Current owed to participating38.17143.17150.87102.37105.26
Current owed to group member49.00
Short-term deferred tax liabilities483.40
Other non-interest bearing current liabilities3.753.753.753.753.75
Current liabilities total90.92146.92638.02106.12109.01
Balance sheet total (liabilities)404.971 044.251 432.95690.41805.59
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.